

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.28461940 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77319055 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 3.77319055 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77319055 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77319055 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77319055 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 3.77319055 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.68283741 |
| 9 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.51516438 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50550671 |
| 11 | surfactant homeostasis (GO:0043129) | 3.43022899 |
| 12 | regulation of mononuclear cell migration (GO:0071675) | 3.42942112 |
| 13 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33723560 |
| 14 | lymph vessel development (GO:0001945) | 3.29790470 |
| 15 | protein localization to endosome (GO:0036010) | 3.25795385 |
| 16 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.25702895 |
| 17 | fibroblast migration (GO:0010761) | 3.23607501 |
| 18 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.23119085 |
| 19 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.19911749 |
| 20 | virion attachment to host cell (GO:0019062) | 3.16386508 |
| 21 | adhesion of symbiont to host cell (GO:0044650) | 3.16386508 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.12896753 |
| 23 | barbed-end actin filament capping (GO:0051016) | 3.06700353 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04012017 |
| 25 | germinal center formation (GO:0002467) | 2.98735393 |
| 26 | glycosphingolipid catabolic process (GO:0046479) | 2.98322272 |
| 27 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.94744515 |
| 28 | substrate-dependent cell migration (GO:0006929) | 2.94106790 |
| 29 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.93296658 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92470193 |
| 31 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.86985732 |
| 32 | cell adhesion mediated by integrin (GO:0033627) | 2.86681632 |
| 33 | lymphangiogenesis (GO:0001946) | 2.85432882 |
| 34 | regulation of endothelial cell differentiation (GO:0045601) | 2.83952036 |
| 35 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.83379961 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 2.82104484 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 2.81315542 |
| 38 | adhesion of symbiont to host (GO:0044406) | 2.79641646 |
| 39 | response to host immune response (GO:0052572) | 2.79506716 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79506716 |
| 41 | cardiac myofibril assembly (GO:0055003) | 2.79202981 |
| 42 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78467713 |
| 43 | blood vessel maturation (GO:0001955) | 2.77512108 |
| 44 | growth hormone receptor signaling pathway (GO:0060396) | 2.76653497 |
| 45 | regulation of cholesterol storage (GO:0010885) | 2.74511178 |
| 46 | axon extension involved in axon guidance (GO:0048846) | 2.74228365 |
| 47 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.74228365 |
| 48 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.74007818 |
| 49 | regulation of fever generation (GO:0031620) | 2.73571560 |
| 50 | myofibril assembly (GO:0030239) | 2.70737147 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69186174 |
| 52 | positive regulation of heat generation (GO:0031652) | 2.67444691 |
| 53 | stress fiber assembly (GO:0043149) | 2.67250085 |
| 54 | regulation of macrophage chemotaxis (GO:0010758) | 2.67179042 |
| 55 | oligosaccharide catabolic process (GO:0009313) | 2.65649368 |
| 56 | regulation of podosome assembly (GO:0071801) | 2.64563148 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 2.64107601 |
| 58 | chemical homeostasis within a tissue (GO:0048875) | 2.63604608 |
| 59 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.63568231 |
| 60 | glycolipid catabolic process (GO:0019377) | 2.62423089 |
| 61 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60975119 |
| 62 | neutrophil activation involved in immune response (GO:0002283) | 2.60730607 |
| 63 | basement membrane organization (GO:0071711) | 2.60330295 |
| 64 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58430481 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.58343264 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58326449 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56975834 |
| 68 | response to host (GO:0075136) | 2.56975834 |
| 69 | response to host defenses (GO:0052200) | 2.56975834 |
| 70 | neutrophil activation (GO:0042119) | 2.54551554 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54225011 |
| 72 | positive regulation of type 2 immune response (GO:0002830) | 2.53643027 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51099302 |
| 74 | wound healing, spreading of epidermal cells (GO:0035313) | 2.50537346 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.50483725 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49842067 |
| 77 | I-kappaB phosphorylation (GO:0007252) | 2.48954304 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.48223933 |
| 79 | positive regulation of vasculogenesis (GO:2001214) | 2.47997382 |
| 80 | response to peptidoglycan (GO:0032494) | 2.47824171 |
| 81 | negative regulation of lipid storage (GO:0010888) | 2.46204037 |
| 82 | endothelium development (GO:0003158) | 2.45914296 |
| 83 | glomerular filtration (GO:0003094) | 2.44605342 |
| 84 | regulation of macrophage cytokine production (GO:0010935) | 2.44497678 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.43630318 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42234737 |
| 87 | keratan sulfate catabolic process (GO:0042340) | 2.41229212 |
| 88 | response to laminar fluid shear stress (GO:0034616) | 2.40763695 |
| 89 | granulocyte activation (GO:0036230) | 2.40312804 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.39689642 |
| 91 | regulation of vasculogenesis (GO:2001212) | 2.39303678 |
| 92 | ganglion development (GO:0061548) | 2.38635802 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.38085112 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36855368 |
| 95 | cellular response to growth hormone stimulus (GO:0071378) | 2.36637933 |
| 96 | microglial cell activation (GO:0001774) | 2.35505642 |
| 97 | venous blood vessel morphogenesis (GO:0048845) | 2.34543249 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34321782 |
| 99 | positive regulation of receptor recycling (GO:0001921) | 2.34152564 |
| 100 | regulation of integrin activation (GO:0033623) | 2.33894029 |
| 101 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.32463630 |
| 102 | regulation of chemokine biosynthetic process (GO:0045073) | 2.32356637 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30736128 |
| 104 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30658814 |
| 105 | response to thyroid hormone (GO:0097066) | 2.30164993 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 2.29883187 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.29877154 |
| 108 | cellular response to type I interferon (GO:0071357) | 2.29877154 |
| 109 | patterning of blood vessels (GO:0001569) | 2.29472494 |
| 110 | apoptotic cell clearance (GO:0043277) | 2.28467330 |
| 111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.28070886 |
| 112 | cellular response to lipopolysaccharide (GO:0071222) | 2.27854228 |
| 113 | response to type I interferon (GO:0034340) | 2.27586448 |
| 114 | negative regulation of cell killing (GO:0031342) | 2.26409320 |
| 115 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26409320 |
| 116 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.25636756 |
| 117 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.25493817 |
| 118 | cellular extravasation (GO:0045123) | 2.25176532 |
| 119 | detection of other organism (GO:0098543) | 2.24353586 |
| 120 | amino sugar catabolic process (GO:0046348) | 2.23215409 |
| 121 | regulation of cellular extravasation (GO:0002691) | 2.22921915 |
| 122 | ceramide catabolic process (GO:0046514) | 2.22777310 |
| 123 | establishment of endothelial barrier (GO:0061028) | 2.22198297 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.21792693 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 2.21495008 |
| 126 | cellular response to molecule of bacterial origin (GO:0071219) | 2.21490446 |
| 127 | positive regulation of cholesterol efflux (GO:0010875) | 2.21339662 |
| 128 | endothelial cell morphogenesis (GO:0001886) | 2.21047052 |
| 129 | morphogenesis of an endothelium (GO:0003159) | 2.20468942 |
| 130 | endothelial tube morphogenesis (GO:0061154) | 2.20468942 |
| 131 | regulation of T cell tolerance induction (GO:0002664) | 2.20043083 |
| 132 | macrophage activation (GO:0042116) | 2.19888448 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.19865890 |
| 134 | renal filtration (GO:0097205) | 2.19270564 |
| 135 | coronary vasculature morphogenesis (GO:0060977) | 2.19203290 |
| 136 | peptide catabolic process (GO:0043171) | 2.19187039 |
| 137 | adenosine receptor signaling pathway (GO:0001973) | 2.19089913 |
| 138 | mannose metabolic process (GO:0006013) | 2.18966483 |
| 139 | regulation of type 2 immune response (GO:0002828) | 2.18807096 |
| 140 | regulation of antigen processing and presentation (GO:0002577) | 2.18327332 |
| 141 | regulation of cardioblast differentiation (GO:0051890) | 2.17356073 |
| 142 | Notch signaling involved in heart development (GO:0061314) | 2.17111142 |
| 143 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.16571034 |
| 144 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.16305194 |
| 145 | angiogenesis involved in wound healing (GO:0060055) | 2.15586108 |
| 146 | pinocytosis (GO:0006907) | 2.14848760 |
| 147 | monocyte chemotaxis (GO:0002548) | 2.14214843 |
| 148 | sarcomere organization (GO:0045214) | 2.14171238 |
| 149 | atrial septum morphogenesis (GO:0060413) | 2.14038741 |
| 150 | positive regulation of interleukin-12 production (GO:0032735) | 2.13561145 |
| 151 | T-helper 1 type immune response (GO:0042088) | 2.13167835 |
| 152 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.12447515 |
| 153 | superoxide anion generation (GO:0042554) | 2.12309548 |
| 154 | negative regulation of granulocyte differentiation (GO:0030853) | 2.11804614 |
| 155 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.11642809 |
| 156 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.10478968 |
| 157 | response to fluid shear stress (GO:0034405) | 2.10073671 |
| 158 | atrioventricular valve morphogenesis (GO:0003181) | 2.10046643 |
| 159 | regulation of relaxation of muscle (GO:1901077) | 2.09978342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25259835 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.97525219 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36464833 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.13179804 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.94347220 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.73050827 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54718706 |
| 8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.43411019 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29616152 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28906907 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26164049 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23803734 |
| 13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23366350 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12720631 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.98262359 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98149119 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94836755 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94821794 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86876486 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84281159 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83988931 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79957288 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76105240 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73633584 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68876311 |
| 26 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56097532 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55672135 |
| 28 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52070278 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.49212178 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47664100 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46140191 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44489998 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42167769 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40836160 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40434039 |
| 36 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39824578 |
| 37 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39824578 |
| 38 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38349305 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37258719 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36343564 |
| 41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27685102 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27171607 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26966734 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25961875 |
| 45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25260790 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24344065 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22444112 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21882525 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20414347 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20414347 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19284607 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18152001 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18126723 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17999620 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17586740 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16597261 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16326881 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15237508 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14446444 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13614528 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12619049 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12122337 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12119258 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11366330 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11321326 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10780320 |
| 67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10414210 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10017774 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08355956 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08317942 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07166282 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07032622 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06551430 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06551430 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06313246 |
| 76 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05568096 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05282752 |
| 78 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04458599 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02150877 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01434943 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00589532 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00553839 |
| 83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99756617 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99407875 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99378876 |
| 86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99333607 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98935345 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98776601 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98627213 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98528372 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97107781 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96870592 |
| 93 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96690562 |
| 94 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95639153 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95587259 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95337189 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95201697 |
| 98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94270945 |
| 99 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94242775 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93950804 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91874216 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91738220 |
| 103 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91598987 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91514613 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91378519 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90165507 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89967221 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89966521 |
| 109 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89890423 |
| 110 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.89557471 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89033907 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88660747 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88588681 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88352263 |
| 115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88114925 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87143204 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86990317 |
| 118 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86831787 |
| 119 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86831787 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86540839 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86496193 |
| 122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86391852 |
| 123 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86078965 |
| 124 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85737883 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85155681 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85049527 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84378638 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84018370 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83750018 |
| 130 | MAF_26560356_Chip-Seq_TH1_Human | 0.82199897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.48762995 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 3.41775556 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.39840855 |
| 4 | MP0004084_abnormal_cardiac_muscle | 2.72994611 |
| 5 | MP0003828_pulmonary_edema | 2.66101825 |
| 6 | MP0003724_increased_susceptibility_to | 2.64371863 |
| 7 | MP0004272_abnormal_basement_membrane | 2.54929299 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.46509408 |
| 9 | MP0009840_abnormal_foam_cell | 2.36576836 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.29930896 |
| 11 | MP0001958_emphysema | 2.28105383 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.23448177 |
| 13 | MP0000767_abnormal_smooth_muscle | 2.17207544 |
| 14 | MP0003279_aneurysm | 2.15797224 |
| 15 | MP0009278_abnormal_bone_marrow | 2.10871139 |
| 16 | MP0003303_peritoneal_inflammation | 2.05894387 |
| 17 | MP0003091_abnormal_cell_migration | 1.95662431 |
| 18 | MP0003075_altered_response_to | 1.91068733 |
| 19 | MP0000569_abnormal_digit_pigmentation | 1.87119796 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.86242152 |
| 21 | MP0008775_abnormal_heart_ventricle | 1.85494516 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.84832350 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.81491558 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.81092866 |
| 25 | MP0003436_decreased_susceptibility_to | 1.79447776 |
| 26 | MP0000343_altered_response_to | 1.77004639 |
| 27 | MP0002419_abnormal_innate_immunity | 1.75850223 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.74052008 |
| 29 | MP0008004_abnormal_stomach_pH | 1.71649529 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.68933567 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.67758634 |
| 32 | MP0005387_immune_system_phenotype | 1.67648337 |
| 33 | MP0001790_abnormal_immune_system | 1.67648337 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.66199635 |
| 35 | MP0000604_amyloidosis | 1.63833171 |
| 36 | MP0003690_abnormal_glial_cell | 1.62479744 |
| 37 | MP0009785_altered_susceptibility_to | 1.59840467 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.56635093 |
| 39 | MP0005451_abnormal_body_composition | 1.54929226 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.52488352 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.50802528 |
| 42 | MP0000685_abnormal_immune_system | 1.48128630 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.45781150 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.45347673 |
| 45 | MP0002006_tumorigenesis | 1.42822468 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.42678335 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.42340668 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.41633007 |
| 49 | MP0003448_altered_tumor_morphology | 1.40879287 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.39991367 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.39024761 |
| 52 | MP0006138_congestive_heart_failure | 1.36713092 |
| 53 | MP0001544_abnormal_cardiovascular_syste | 1.35061474 |
| 54 | MP0005385_cardiovascular_system_phenoty | 1.35061474 |
| 55 | MP0003045_fibrosis | 1.33364481 |
| 56 | MP0005166_decreased_susceptibility_to | 1.31716812 |
| 57 | MP0005171_absent_coat_pigmentation | 1.31257524 |
| 58 | MP0005025_abnormal_response_to | 1.30824445 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.30285178 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.29695439 |
| 61 | MP0000249_abnormal_blood_vessel | 1.26713640 |
| 62 | MP0005023_abnormal_wound_healing | 1.24988949 |
| 63 | MP0000751_myopathy | 1.20284106 |
| 64 | MP0002254_reproductive_system_inflammat | 1.19781020 |
| 65 | MP0004484_altered_response_of | 1.18930208 |
| 66 | MP0005330_cardiomyopathy | 1.18391937 |
| 67 | MP0002723_abnormal_immune_serum | 1.18277134 |
| 68 | MP0005671_abnormal_response_to | 1.17413662 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.17184350 |
| 70 | MP0000733_abnormal_muscle_development | 1.17041409 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.16908087 |
| 72 | MP0000920_abnormal_myelination | 1.16853565 |
| 73 | MP0001800_abnormal_humoral_immune | 1.14357600 |
| 74 | MP0002933_joint_inflammation | 1.13652378 |
| 75 | MP0004130_abnormal_muscle_cell | 1.13451182 |
| 76 | MP0004087_abnormal_muscle_fiber | 1.13074228 |
| 77 | MP0009764_decreased_sensitivity_to | 1.12611478 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.12034208 |
| 79 | MP0001819_abnormal_immune_cell | 1.11262223 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.10500034 |
| 81 | MP0001542_abnormal_bone_strength | 1.10315700 |
| 82 | MP0002128_abnormal_blood_circulation | 1.09927331 |
| 83 | MP0005595_abnormal_vascular_smooth | 1.09420664 |
| 84 | MP0002420_abnormal_adaptive_immunity | 1.08558914 |
| 85 | MP0000858_altered_metastatic_potential | 1.05262712 |
| 86 | MP0002405_respiratory_system_inflammati | 1.05106861 |
| 87 | MP0001853_heart_inflammation | 1.04291815 |
| 88 | MP0006082_CNS_inflammation | 1.02523950 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 1.02286111 |
| 90 | MP0001545_abnormal_hematopoietic_system | 1.02286111 |
| 91 | MP0001614_abnormal_blood_vessel | 1.01331413 |
| 92 | MP0002925_abnormal_cardiovascular_devel | 1.00598686 |
| 93 | MP0005164_abnormal_response_to | 0.99411050 |
| 94 | MP0000749_muscle_degeneration | 0.99326594 |
| 95 | MP0005165_increased_susceptibility_to | 0.98941830 |
| 96 | MP0005275_abnormal_skin_tensile | 0.97710662 |
| 97 | MP0005390_skeleton_phenotype | 0.97189346 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.96799230 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.96650779 |
| 100 | MP0002133_abnormal_respiratory_system | 0.96156016 |
| 101 | MP0005388_respiratory_system_phenotype | 0.96156016 |
| 102 | MP0001851_eye_inflammation | 0.95650647 |
| 103 | MP0003329_amyloid_beta_deposits | 0.95622117 |
| 104 | MP0008469_abnormal_protein_level | 0.95121740 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.95083583 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.92312940 |
| 107 | MP0002009_preneoplasia | 0.89605285 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.89223455 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.88638501 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.87873959 |
| 111 | MP0003191_abnormal_cellular_cholesterol | 0.87753449 |
| 112 | MP0006054_spinal_hemorrhage | 0.86817003 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.86630167 |
| 114 | MP0004947_skin_inflammation | 0.86312505 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.86028403 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.85396509 |
| 117 | MP0004883_abnormal_blood_vessel | 0.84989361 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.83721616 |
| 119 | MP0003941_abnormal_skin_development | 0.83570836 |
| 120 | MP0000371_diluted_coat_color | 0.83532878 |
| 121 | MP0005409_darkened_coat_color | 0.83118619 |
| 122 | MP0005670_abnormal_white_adipose | 0.82848890 |
| 123 | MP0003795_abnormal_bone_structure | 0.81573330 |
| 124 | MP0003634_abnormal_glial_cell | 0.79934468 |
| 125 | MP0001849_ear_inflammation | 0.77334746 |
| 126 | MP0001915_intracranial_hemorrhage | 0.75040294 |
| 127 | MP0005310_abnormal_salivary_gland | 0.74328616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.46870989 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.46870989 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.46870989 |
| 4 | Hematochezia (HP:0002573) | 4.29384658 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.85930413 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.72283387 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.67644996 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.63295907 |
| 9 | Broad metatarsal (HP:0001783) | 3.41855140 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.39581049 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.29366572 |
| 12 | Orchitis (HP:0100796) | 3.21633071 |
| 13 | Polycythemia (HP:0001901) | 3.07096576 |
| 14 | Loss of speech (HP:0002371) | 3.06839102 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.04931112 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.02187453 |
| 17 | Optic neuritis (HP:0100653) | 3.02187453 |
| 18 | Sudden death (HP:0001699) | 2.99235979 |
| 19 | Neurofibrillary tangles (HP:0002185) | 2.95705803 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 2.93096839 |
| 21 | Atrial fibrillation (HP:0005110) | 2.91212265 |
| 22 | Myositis (HP:0100614) | 2.90674856 |
| 23 | Ventricular tachycardia (HP:0004756) | 2.89670617 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89193515 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89193515 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89193515 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85408110 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.85408110 |
| 29 | Aortic aneurysm (HP:0004942) | 2.83475242 |
| 30 | Nuclear cataract (HP:0100018) | 2.70151917 |
| 31 | Aortic dissection (HP:0002647) | 2.66577410 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 2.66189988 |
| 33 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.60734471 |
| 34 | Arterial thrombosis (HP:0004420) | 2.57712155 |
| 35 | Lipoatrophy (HP:0100578) | 2.56639702 |
| 36 | Disinhibition (HP:0000734) | 2.56384902 |
| 37 | Supraventricular arrhythmia (HP:0005115) | 2.51601758 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.50957247 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.50086103 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.48376661 |
| 41 | Premature rupture of membranes (HP:0001788) | 2.47338890 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46952703 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.46525661 |
| 44 | Supraventricular tachycardia (HP:0004755) | 2.42249960 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41983984 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.41983984 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.41188181 |
| 48 | Subaortic stenosis (HP:0001682) | 2.40071588 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.40071588 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.40048223 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.39737412 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.38332686 |
| 53 | Peritonitis (HP:0002586) | 2.36299806 |
| 54 | Gingivitis (HP:0000230) | 2.30741736 |
| 55 | Hypoplasia of the iris (HP:0007676) | 2.29824403 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.28625841 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.27920198 |
| 58 | * Pulmonary artery stenosis (HP:0004415) | 2.27770998 |
| 59 | Myocardial infarction (HP:0001658) | 2.27401172 |
| 60 | Glomerulonephritis (HP:0000099) | 2.26955314 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.26798614 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26357801 |
| 63 | Conjunctival telangiectasia (HP:0000524) | 2.26251071 |
| 64 | Increased connective tissue (HP:0009025) | 2.25221867 |
| 65 | Thick nail (HP:0001805) | 2.23788021 |
| 66 | Arterial tortuosity (HP:0005116) | 2.23283554 |
| 67 | Mutism (HP:0002300) | 2.23268115 |
| 68 | Vascular tortuosity (HP:0004948) | 2.20582013 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.20063758 |
| 70 | Amyloidosis (HP:0011034) | 2.16525312 |
| 71 | Shallow orbits (HP:0000586) | 2.16149127 |
| 72 | Aneurysm (HP:0002617) | 2.15654230 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.14768098 |
| 74 | Hemoptysis (HP:0002105) | 2.12043991 |
| 75 | Asymmetry of the thorax (HP:0001555) | 2.11924882 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.09677767 |
| 77 | Apathy (HP:0000741) | 2.09019011 |
| 78 | * Esophageal varix (HP:0002040) | 2.08203431 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.07805534 |
| 80 | Prolonged QT interval (HP:0001657) | 2.06897971 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03507618 |
| 82 | Tetraparesis (HP:0002273) | 2.02875307 |
| 83 | Diminished motivation (HP:0000745) | 1.98157026 |
| 84 | Abnormality of the endocardium (HP:0004306) | 1.97213648 |
| 85 | Upper motor neuron abnormality (HP:0002127) | 1.95604624 |
| 86 | Eosinophilia (HP:0001880) | 1.95566753 |
| 87 | Abnormality of the ischium (HP:0003174) | 1.95029988 |
| 88 | Complement deficiency (HP:0004431) | 1.93903192 |
| 89 | Thin bony cortex (HP:0002753) | 1.93640224 |
| 90 | Recurrent skin infections (HP:0001581) | 1.90893231 |
| 91 | Absent frontal sinuses (HP:0002688) | 1.89963196 |
| 92 | * Pulmonary hypertension (HP:0002092) | 1.89930600 |
| 93 | Leukocytosis (HP:0001974) | 1.89333265 |
| 94 | Pigmentary retinal degeneration (HP:0001146) | 1.89157651 |
| 95 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89046162 |
| 96 | Persistence of primary teeth (HP:0006335) | 1.88749113 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 1.88272361 |
| 98 | Emphysema (HP:0002097) | 1.87760388 |
| 99 | Abnormality of the calf musculature (HP:0001430) | 1.87568610 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 1.87471965 |
| 101 | Recurrent viral infections (HP:0004429) | 1.85772728 |
| 102 | Mitral valve prolapse (HP:0001634) | 1.85006348 |
| 103 | Axonal loss (HP:0003447) | 1.84940059 |
| 104 | Vasculitis (HP:0002633) | 1.84905096 |
| 105 | Restrictive lung disease (HP:0002091) | 1.84143419 |
| 106 | Abnormality of the pericardium (HP:0001697) | 1.83868517 |
| 107 | Increased CSF protein (HP:0002922) | 1.83231718 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 1.82664529 |
| 109 | Cervical subluxation (HP:0003308) | 1.82604222 |
| 110 | Prostate neoplasm (HP:0100787) | 1.82061890 |
| 111 | Joint stiffness (HP:0001387) | 1.81606679 |
| 112 | Ovoid vertebral bodies (HP:0003300) | 1.81508204 |
| 113 | Syncope (HP:0001279) | 1.80596580 |
| 114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79093345 |
| 115 | Fatigue (HP:0012378) | 1.79073972 |
| 116 | Syringomyelia (HP:0003396) | 1.78980256 |
| 117 | Spinal cord lesions (HP:0100561) | 1.78980256 |
| 118 | Hemangiomatosis (HP:0007461) | 1.77082131 |
| 119 | Visceral angiomatosis (HP:0100761) | 1.76868967 |
| 120 | Bicuspid aortic valve (HP:0001647) | 1.76247359 |
| 121 | Abnormality of complement system (HP:0005339) | 1.75275607 |
| 122 | Atrophic scars (HP:0001075) | 1.74994860 |
| 123 | Spinal rigidity (HP:0003306) | 1.74226148 |
| 124 | Periodontitis (HP:0000704) | 1.73780039 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 1.73500744 |
| 126 | Cellulitis (HP:0100658) | 1.73188112 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 1.72905826 |
| 128 | EMG: myopathic abnormalities (HP:0003458) | 1.72593137 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.72536061 |
| 130 | Wormian bones (HP:0002645) | 1.72437485 |
| 131 | Spondylolisthesis (HP:0003302) | 1.72176065 |
| 132 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71960821 |
| 133 | Cerebral hemorrhage (HP:0001342) | 1.71702691 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 1.71625459 |
| 135 | Stomach cancer (HP:0012126) | 1.70528911 |
| 136 | Purpura (HP:0000979) | 1.69921649 |
| 137 | Basal ganglia calcification (HP:0002135) | 1.69785220 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69309392 |
| 139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69309392 |
| 140 | Lymphangioma (HP:0100764) | 1.69064927 |
| 141 | Hypoplastic left heart (HP:0004383) | 1.68941081 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 1.67764369 |
| 143 | Mucosal telangiectasiae (HP:0100579) | 1.67097849 |
| 144 | Bone pain (HP:0002653) | 1.67065490 |
| 145 | Chest pain (HP:0100749) | 1.65699821 |
| 146 | Protuberant abdomen (HP:0001538) | 1.61463157 |
| 147 | Overgrowth (HP:0001548) | 1.60858993 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.60265315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.42180892 |
| 2 | MAP3K14 | 3.24422110 |
| 3 | KDR | 3.10686719 |
| 4 | TGFBR2 | 3.08927000 |
| 5 | PRPF4B | 2.54156139 |
| 6 | RIPK1 | 2.45937556 |
| 7 | TTN | 2.39923684 |
| 8 | TYK2 | 2.16799719 |
| 9 | JAK1 | 2.11194317 |
| 10 | TBK1 | 2.05541542 |
| 11 | JAK3 | 1.95455203 |
| 12 | DMPK | 1.91698977 |
| 13 | IKBKB | 1.80123974 |
| 14 | EPHB1 | 1.72868222 |
| 15 | TRIB3 | 1.65841460 |
| 16 | MOS | 1.63599272 |
| 17 | IRAK4 | 1.63192349 |
| 18 | CHUK | 1.62640045 |
| 19 | IRAK3 | 1.59953424 |
| 20 | IKBKE | 1.58658732 |
| 21 | STK24 | 1.58015005 |
| 22 | MAP3K13 | 1.52026120 |
| 23 | CAMK1D | 1.45940095 |
| 24 | PTK6 | 1.43648054 |
| 25 | FGFR3 | 1.43567372 |
| 26 | TAOK2 | 1.43007607 |
| 27 | FGR | 1.40856103 |
| 28 | MYLK | 1.36139436 |
| 29 | PDGFRA | 1.35366743 |
| 30 | KIT | 1.34095850 |
| 31 | EPHA3 | 1.32692667 |
| 32 | MATK | 1.32526343 |
| 33 | PKN2 | 1.26675886 |
| 34 | BLK | 1.26134877 |
| 35 | NEK9 | 1.22791576 |
| 36 | TRPM7 | 1.22788732 |
| 37 | INSRR | 1.22550839 |
| 38 | RIPK4 | 1.22500789 |
| 39 | TXK | 1.21818602 |
| 40 | CAMK1G | 1.19261964 |
| 41 | MAP4K1 | 1.17339315 |
| 42 | CSK | 1.09554136 |
| 43 | PDGFRB | 1.07311921 |
| 44 | OBSCN | 1.06752988 |
| 45 | PTK2B | 1.05767492 |
| 46 | PIK3CA | 1.05310726 |
| 47 | PRKAA2 | 1.04558664 |
| 48 | ZAK | 1.04449682 |
| 49 | NME2 | 1.02008499 |
| 50 | BMX | 0.98781600 |
| 51 | NUAK1 | 0.98479827 |
| 52 | PKN1 | 0.96820356 |
| 53 | SIK1 | 0.96374924 |
| 54 | MAP2K3 | 0.96354974 |
| 55 | FGFR4 | 0.95205048 |
| 56 | LATS2 | 0.94225511 |
| 57 | TGFBR1 | 0.92486964 |
| 58 | MAP3K1 | 0.88053792 |
| 59 | TYRO3 | 0.88052929 |
| 60 | PIM2 | 0.86871703 |
| 61 | TEC | 0.86836772 |
| 62 | MARK3 | 0.86031801 |
| 63 | MAP3K11 | 0.85965769 |
| 64 | STK3 | 0.85797419 |
| 65 | RPS6KA2 | 0.82756053 |
| 66 | EPHB2 | 0.81291927 |
| 67 | HCK | 0.79913835 |
| 68 | ZAP70 | 0.79675460 |
| 69 | LATS1 | 0.78757603 |
| 70 | JAK2 | 0.77547549 |
| 71 | ABL2 | 0.76579673 |
| 72 | IRAK1 | 0.74851676 |
| 73 | PRKD1 | 0.74754090 |
| 74 | ICK | 0.74378421 |
| 75 | LMTK2 | 0.73700650 |
| 76 | TAOK1 | 0.73560975 |
| 77 | GRK1 | 0.73511207 |
| 78 | STK10 | 0.71366462 |
| 79 | CSF1R | 0.70682232 |
| 80 | NLK | 0.69666334 |
| 81 | BMPR2 | 0.68837010 |
| 82 | SYK | 0.66347420 |
| 83 | MAPK4 | 0.66140860 |
| 84 | MARK2 | 0.65589428 |
| 85 | ERN1 | 0.65423539 |
| 86 | FES | 0.64119303 |
| 87 | EIF2AK2 | 0.63348444 |
| 88 | MAPK12 | 0.62847566 |
| 89 | CDK6 | 0.60606879 |
| 90 | LYN | 0.60272355 |
| 91 | KSR2 | 0.60012345 |
| 92 | PDPK1 | 0.59670040 |
| 93 | LCK | 0.59622440 |
| 94 | EGFR | 0.58906125 |
| 95 | WNK1 | 0.58366292 |
| 96 | PAK4 | 0.58336654 |
| 97 | IRAK2 | 0.58222753 |
| 98 | PTK2 | 0.57638828 |
| 99 | MAP3K5 | 0.55228322 |
| 100 | PIK3CG | 0.55121285 |
| 101 | MAP3K3 | 0.54605673 |
| 102 | RPS6KC1 | 0.54411675 |
| 103 | RPS6KL1 | 0.54411675 |
| 104 | ROCK2 | 0.53962012 |
| 105 | LRRK2 | 0.53676744 |
| 106 | MAP3K7 | 0.53616882 |
| 107 | ROCK1 | 0.52896864 |
| 108 | IGF1R | 0.52343409 |
| 109 | PRKCH | 0.52218393 |
| 110 | CLK1 | 0.51614174 |
| 111 | PDK2 | 0.51252909 |
| 112 | MAPK7 | 0.50947938 |
| 113 | ABL1 | 0.50155187 |
| 114 | MAP3K6 | 0.49935011 |
| 115 | SGK3 | 0.49660220 |
| 116 | SGK2 | 0.48921831 |
| 117 | PRKCQ | 0.48904992 |
| 118 | PRKD2 | 0.48734468 |
| 119 | RET | 0.48501057 |
| 120 | PAK2 | 0.48445172 |
| 121 | RPS6KA4 | 0.48411858 |
| 122 | CAMK4 | 0.48290021 |
| 123 | ITK | 0.47656840 |
| 124 | STK4 | 0.47476771 |
| 125 | FER | 0.47390362 |
| 126 | DDR2 | 0.46110295 |
| 127 | GRK7 | 0.46022819 |
| 128 | PRKG2 | 0.45738300 |
| 129 | PRKCE | 0.45194079 |
| 130 | PDK1 | 0.44978384 |
| 131 | PIM1 | 0.43985522 |
| 132 | CAMKK2 | 0.42891997 |
| 133 | NTRK1 | 0.42760671 |
| 134 | LIMK1 | 0.42421688 |
| 135 | TAOK3 | 0.41945144 |
| 136 | EEF2K | 0.41741246 |
| 137 | CDC42BPA | 0.41430266 |
| 138 | FLT3 | 0.41237795 |
| 139 | BTK | 0.40795724 |
| 140 | INSR | 0.40641678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27266089 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01014601 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99589419 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.91198061 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90579626 |
| 6 | Malaria_Homo sapiens_hsa05144 | 1.89278907 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.86963718 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79735425 |
| 9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79698931 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.78641827 |
| 11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.69849034 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.68904928 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.58827908 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56392650 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.55957638 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50606587 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49322946 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.43948758 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.43499738 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41038912 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.39331205 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.38983998 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35759904 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33330654 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32762388 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32569967 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.31951317 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27244115 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.27058032 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.24996193 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22014645 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20468281 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20378417 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20171380 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.19411632 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.18793174 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.18711790 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17585881 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17163081 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15896434 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15764964 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.13216918 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.13153599 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13095498 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12274676 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12128859 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09346063 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06985564 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.03552676 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03159105 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96722872 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.96109308 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96001752 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.95582736 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93170726 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91799600 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91568293 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91371302 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91055608 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91038041 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.88749520 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.88705752 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87710549 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87161914 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87003252 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86267191 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86008842 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85358116 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.84897542 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.83727657 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82395193 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.82291365 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80378873 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80286541 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79464993 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77470148 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77154427 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76413278 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75636890 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74469838 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70233738 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69226019 |
| 83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69188323 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69174244 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68979468 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68918000 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68873816 |
| 88 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68741653 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68493596 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66823478 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64808821 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.63098024 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62806178 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62123063 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61991467 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61932024 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60280618 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58722138 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58666256 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.58095531 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57945126 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57562592 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56549889 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55150304 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.52791633 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52522083 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52257083 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51972865 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.51675795 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49594063 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46796279 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45871897 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.40823775 |

